Adaptive Biotech CEO says it’s working to develop the best antibody treatment for Covid-19

Adaptive biotechnologies CEO Chad Robins says the company is working night and day to develop an effective antibody Covid-19 treatment. He says the company won't be first to provide antibody treatments, but once developed it will help many patients across the United States. He joins 'Closing Bell' to discuss.
Thu, Oct 22 20204:58 PM EDT